$CAQ Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VIA Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in VIA Pharmaceuticals, Inc.. Get notifications about new insider transactions in VIA Pharmaceuticals, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11 2004 | CAQ | VIA Pharmaceutical ... | MERRIMAN RONALD | Director | Buy | P | 5.50 | 1,500 | 8,250 | 1,500 | 0 to 1.5 K |
| May 11 2004 | CAQ | VIA Pharmaceutical ... | LARSON JOHN RANDOLPH | Director | Option Exercise | A | 5.50 | 21,000 | 115,500 | 21,000 | |
| May 11 2004 | CAQ | VIA Pharmaceutical ... | LARSON JOHN RANDOLPH | Director | Option Exercise | A | 5.50 | 1,000 | 5,500 | 1,000 | |
| May 11 2004 | CAQ | VIA Pharmaceutical ... | LARSON JOHN RANDOLPH | Director | Buy | P | 5.50 | 18,000 | 99,000 | 23,482 | 5.5 K to 23.5 K (+328.35 %) |
| May 11 2004 | CAQ | VIA Pharmaceutical ... | GILSTRAP JAMES C | Director | Option Exercise | A | 5.50 | 18,000 | 99,000 | 18,000 | |
| May 11 2004 | CAQ | VIA Pharmaceutical ... | GILSTRAP JAMES C | Director | Buy | P | 5.50 | 25,000 | 137,500 | 30,427 | 5.4 K to 30.4 K (+460.66 %) |
| May 11 2004 | CAQ | VIA Pharmaceutical ... | FALKENBERG ERIC N | Director | Option Exercise | A | 5.50 | 21,000 | 115,500 | 21,000 | |
| May 11 2004 | CAQ | VIA Pharmaceutical ... | FALKENBERG ERIC N | Director | Option Exercise | A | 5.50 | 1,000 | 5,500 | 1,000 | |
| May 11 2004 | CAQ | VIA Pharmaceutical ... | FALKENBERG ERIC N | Director | Buy | P | 5.50 | 10,000 | 55,000 | 10,000 | 0 to 10 K |
| May 11 2004 | CAQ | VIA Pharmaceutical ... | CALLICUTT JACK W | VP-Finance&Admin, C ... | Buy | P | 5.50 | 1,000 | 5,500 | 1,000 | 0 to 1,000 |
| Apr 19 2004 | CAQ | VIA Pharmaceutical ... | SCHMITT VICTOR W | Director | Option Exercise | A | 6.00 | 1,500 | 9,000 | 1,500 | |
| Apr 19 2004 | CAQ | VIA Pharmaceutical ... | QUADROS PAUL D | Director | Option Exercise | A | 45.50 | 6,844 | 311,402 | 6,844 | |
| Apr 19 2004 | CAQ | VIA Pharmaceutical ... | QUADROS PAUL D | Director | Option Exercise | D | 45.50 | 6,844 | 311,402 | 0 | |
| Apr 19 2004 | CAQ | VIA Pharmaceutical ... | QUADROS PAUL D | Director | Option Exercise | A | 2.24 | 11,700 | 26,208 | 11,700 | |
| Apr 19 2004 | CAQ | VIA Pharmaceutical ... | QUADROS PAUL D | Director | Option Exercise | D | 2.24 | 11,700 | 26,208 | 0 | |
| Apr 19 2004 | CAQ | VIA Pharmaceutical ... | QUADROS PAUL D | Director | Option Exercise | A | 6.00 | 1,500 | 9,000 | 1,500 | |
| Apr 19 2004 | CAQ | VIA Pharmaceutical ... | ROYSTON IVOR | Director | Option Exercise | A | 6.00 | 1,500 | 9,000 | 1,500 | |
| Apr 19 2004 | CAQ | VIA Pharmaceutical ... | LARSON JOHN RANDOLPH | Director | Option Exercise | A | 6.00 | 2,000 | 12,000 | 2,000 | |
| Apr 19 2004 | CAQ | VIA Pharmaceutical ... | PHARAND DANIEL | Director | Option Exercise | A | 6.00 | 2,000 | 12,000 | 2,000 | |
| Apr 19 2004 | CAQ | VIA Pharmaceutical ... | FALKENBERG ERIC N | Director | Option Exercise | A | 6.00 | 500 | 3,000 | 500 | |
| Mar 18 2004 | CAQ | VIA Pharmaceutical ... | SCHMITT VICTOR W | Director | Option Exercise | A | 6.70 | 1,500 | 10,050 | 1,500 | |
| Mar 18 2004 | CAQ | VIA Pharmaceutical ... | QUADROS PAUL D | Director | Option Exercise | A | 6.70 | 1,500 | 10,050 | 1,500 | |
| Mar 18 2004 | CAQ | VIA Pharmaceutical ... | ROYSTON IVOR | Director | Option Exercise | A | 6.70 | 2,000 | 13,400 | 2,000 | |
| Mar 18 2004 | CAQ | VIA Pharmaceutical ... | PHARAND DANIEL | Director | Option Exercise | A | 6.70 | 1,500 | 10,050 | 1,500 | |
| Mar 18 2004 | CAQ | VIA Pharmaceutical ... | LARSON JOHN RANDOLPH | Director | Option Exercise | A | 6.70 | 2,000 | 13,400 | 2,000 | |
| Mar 18 2004 | CAQ | VIA Pharmaceutical ... | FALKENBERG ERIC N | Director | Option Exercise | A | 6.70 | 2,000 | 13,400 | 2,000 | |
| Mar 18 2004 | CAQ | VIA Pharmaceutical ... | GILSTRAP JAMES C | Director | Option Exercise | A | 6.70 | 1,500 | 10,050 | 1,500 | |
| Mar 18 2004 | CAQ | VIA Pharmaceutical ... | CALLICUTT JACK W | VP-Finance&Admin, C ... | Option Exercise | A | 6.70 | 10,000 | 67,000 | 10,000 | |
| Feb 17 2004 | CAQ | VIA Pharmaceutical ... | SCHMITT VICTOR W | Director | Option Exercise | A | 7.00 | 2,000 | 14,000 | 2,000 | |
| Feb 17 2004 | CAQ | VIA Pharmaceutical ... | ROYSTON IVOR | Director | Option Exercise | A | 7.00 | 2,000 | 14,000 | 2,000 | |
| Feb 17 2004 | CAQ | VIA Pharmaceutical ... | QUADROS PAUL D | Director | Option Exercise | A | 7.00 | 1,500 | 10,500 | 1,500 | |
| Feb 17 2004 | CAQ | VIA Pharmaceutical ... | LARSON JOHN RANDOLPH | Director | Option Exercise | A | 7.00 | 2,000 | 14,000 | 2,000 | |
| Feb 17 2004 | CAQ | VIA Pharmaceutical ... | PHARAND DANIEL | Director | Option Exercise | A | 7.00 | 2,000 | 14,000 | 2,000 | |
| Feb 17 2004 | CAQ | VIA Pharmaceutical ... | GILSTRAP JAMES C | Director | Option Exercise | A | 7.00 | 2,000 | 14,000 | 2,000 | |
| Feb 17 2004 | CAQ | VIA Pharmaceutical ... | FALKENBERG ERIC N | Director | Option Exercise | A | 7.00 | 2,000 | 14,000 | 2,000 | |
| Feb 17 2004 | CAQ | VIA Pharmaceutical ... | OTTO RICHARD E | Chief Executive Off ... | Option Exercise | A | 4.50 | 75,000 | 337,500 | 75,000 | |
| Feb 17 2004 | CAQ | VIA Pharmaceutical ... | ATWOOD ROBERT T | CFO, Executive VP | Option Exercise | A | 4.50 | 75,000 | 337,500 | 75,000 |